FDAnews Device Daily Bulletin

88% SENSITIVITY REPORTED FOR STOOL DNA COLORECTAL CANCER SCREENING TECHNOLOGY IN ABSTRACT PRESENTED AT 2006 DDW CONFERENCE

May 23, 2006
A A

EXACT Sciences Corporation announced today that the results of a research study on next generation stool DNA testing technology were presented at the annual Digestive Disease Week (DDW) conference, the world's largest meeting of gastroenterology professionals. Using a simplified panel of markers and a new buffer and DNA capture technology, EXACT's stool DNA technology demonstrated an 88% sensitivity for cancer, with a specificity of 82%.
Genetic Engineering News